Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Allograft rejection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
2 | Allograft rejection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
3 | Allograft rejection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
4 | Allograft rejection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
5 | Antigen processing and presentation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
6 | Asthma 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
7 | Asthma 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
8 | Asthma 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
9 | Asthma 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
10 | Autoimmune thyroid disease 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
11 | Autoimmune thyroid disease 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
12 | Autoimmune thyroid disease 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
13 | Autoimmune thyroid disease 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
14 | Cell adhesion molecules 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
15 | Cell adhesion molecules 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
16 | Cell adhesion molecules 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
17 | Cell adhesion molecules 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
18 | Cell adhesion molecules 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
19 | Cytokine-cytokine receptor interaction 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
20 | Cytokine-cytokine receptor interaction 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
21 | Cytokine-cytokine receptor interaction 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
22 | Cytokine-cytokine receptor interaction 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
23 | Cytokine-cytokine receptor interaction 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
24 | Epstein-Barr virus infection 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
25 | Epstein-Barr virus infection 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
26 | Epstein-Barr virus infection 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
27 | Hematopoietic cell lineage 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
28 | Human immunodeficiency virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
29 | Human T-cell leukemia virus 1 infection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
30 | Human T-cell leukemia virus 1 infection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
31 | Human T-cell leukemia virus 1 infection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
32 | Human T-cell leukemia virus 1 infection 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
33 | Intestinal immune network for IgA production 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
34 | Intestinal immune network for IgA production 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
35 | Intestinal immune network for IgA production 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
36 | Intestinal immune network for IgA production 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
37 | Lipid and atherosclerosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
38 | Lipid and atherosclerosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
39 | Lipid and atherosclerosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
40 | Lipid and atherosclerosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
41 | Malaria 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
42 | Malaria 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
43 | Malaria 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
44 | Malaria 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
45 | NF-kappa B signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
46 | NF-kappa B signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
47 | NF-kappa B signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
48 | NF-kappa B signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
49 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
50 | Primary immunodeficiency 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
51 | Primary immunodeficiency 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
52 | Primary immunodeficiency 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
53 | Primary immunodeficiency 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
54 | Primary immunodeficiency 💬 3 genes, 5 drugs (DrugBank) and 6 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
55 | Systemic lupus erythematosus 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
56 | Systemic lupus erythematosus 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
57 | Systemic lupus erythematosus 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
58 | Systemic lupus erythematosus 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
59 | T cell receptor signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 2 diseases |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
60 | T cell receptor signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 2 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
61 | Th1 and Th2 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
62 | Th17 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
63 | Toll-like receptor signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
64 | Toll-like receptor signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
65 | Toll-like receptor signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
66 | Toxoplasmosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
67 | Toxoplasmosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
68 | Toxoplasmosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
69 | Toxoplasmosis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
70 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
71 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
72 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
73 | Viral life cycle - HIV-1 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
74 | Viral myocarditis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Bleselumab Bleselumab 💬
| Bleselumab | 222 [1] 222 💬
|
75 | Viral myocarditis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Iscalimab Iscalimab 💬
| Iscalimab | 049 [2] 49, 53 💬
|
76 | Viral myocarditis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬
|
Ravagalimab Ravagalimab 💬
| Ravagalimab | 053 [2] 53, 97 💬
|
77 | Viral myocarditis 💬 2 genes, 4 drugs (DrugBank) and 5 diseases |
CD40LG [1] CD40LG 💬
|
Toralizumab Toralizumab 💬
| Toralizumab | 063 [1] 63 💬
|
78 | Virion - Human immunodeficiency virus 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|
79 | Yersinia infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
CD4 [1] CD4 💬
|
Zanolimumab Zanolimumab 💬
| Zanolimumab | 046 [1] 46 💬
|